Digital Health and Health Tech Podcasts

📺 Watch this episode on YouTube: https://youtu.be/aVq-970fIYkLeanne Anderson is the Account Director at Data Capture Experts. Data Capture Experts is a Melbourne-based software company specialising in Digital Workflow Transformation solutions.In this episode, Pete and Leanne discuss digital care coordination, the benefits of getting clinical data upfront for billing and reporting, balancing a purpose-driven and a flexible solution plus, lots more. Check out the episode and full show notes here.To see the latest information, news, events and jobs on offer at Data Capture Experts, visit their Talking HealthTech Directory here. Loving the show? Leave us a review, and share it with someone who might get some value from it.Keen to take your healthtech to the next level? Become a THT+ Member for access to our online community forum, quarterly summits and more exclusive content. For more information visit here.

ONCE UPON A GENE - EPISODE 172 From Cancer Biologist to Rare Disease Mom - Digging Into the Data to Better Understand SCN8A with Madeleine Oudin PhD - Professor of Biomedical Engineering at Tufts Madeleine Oudin is a scientist and Tiampo Family Assistant Professor at Tufts University. Her daughter Margo has two de novo mutations in the SCN8A gene, which causes epilepsy. She's navigating life as a rare, working mom and sharing her knowledge in an understandable and accessible way for other rare parents.  EPISODE HIGHLIGHTS Can you tell us about the epilepsy conference you just attended? The SCN8 community organizes the conference for clinicians, researchers and families every year at the American Epilepsy Society meeting. There were over 35 families in attendance who have children with SCN8A and it was amazing to meet everyone in real life. What advice do you have for parents who aren't sure about attending a conference? Meeting other people has made a big difference for me and I encourage others to find their people. Going to gatherings can lead to finding resources and there's value in connecting to others and learning more about a disease. Community is everything. As a scientist and now a rare parent, how do you look through the microscope differently? The impact of genetic testing surprised me in how vital it is when it comes to rare genetic diseases. When Margo had her first seizure and had genetic testing, the results helped to connect us to community. Genetic testing is vital for families to connect them to resources. What work have you done in the SCN8A community to help other families understand the disease and advance the treatment progress? Science communication is something I'm passionate about. Since becoming a rare mom, I started an Instagram account where I explain the science of the diagnosis and break it down so the information is accessible to everyone. I recently did a webinar breaking down the different treatment strategies for SCN8A.  Can you talk about Margo's acceptance to n-Lorem? We applied with our neurologist and were accepted into the foundation to develop custom Antisense oligonucleotide (ASO) treatments. In parallel, we're doing treatments in my lab on a mouse and mouse cells, testing out different ASOs to see if we can gain any additional insights. LINKS & RESOURCES MENTIONED ONCE UPON A GENE - Episode 139 - Remember Who You Are https://effieparks.com/podcast/139-remember-who-you-are Margot_thebrave on Instagram https://www.instagram.com/margot_thebrave/ SCN8A Alliance   https://scn8aalliance.org/ American Epilepsy Society https://www.ilae.org/ The n-lorem Foundation https://www.nlorem.org/ SCN8A Unraveled https://www.youtube.com/playlist?list=PL-RngxzecxdLsaJFQyerqqfGLarDe9MUt TUNE INTO THE ONCE UPON A GENE PODCAST Spotify https://open.spotify.com/show/5Htr9lt5vXGG3ac6enxLQ7 Apple Podcasts https://podcasts.apple.com/us/podcast/once-upon-a-gene/id1485249347 Stitcher https://www.stitcher.com/podcast/once-upon-a-gene Overcast https://overcast.fm/itunes1485249347/once-upon-a-gene CONNECT WITH EFFIE PARKS Website https://effieparks.com/ Twitter https://twitter.com/OnceUponAGene Instagram https://www.instagram.com/onceuponagene.podcast/?hl=en Built Ford Tough Facebook Group https://www.facebook.com/groups/1877643259173346/ Interested in advertising on Once Upon a Gene? Email [email protected] for more information!

Meet Dr. Steve Hester:Dr. Steven T. Hester is Senior Vice President, System Chief Clinical and Strategy Officer, Norton Healthcare. He joined Norton in 2004 as chief medical information officer, and has served in a number of medical staff and leadership positions in his time since. Prior to joining Norton Healthcare, Dr. Hester practiced emergency medicine full time, working for Kentuckiana Emergency Physicians to improve quality and volume. Dr. Hester hold’s a bachelor’s and medical degree from the University of Louisville and an MBA from Bellarmine University. He serves on multiple national committees and boards focused on improving the delivery of health care for patients. He also serves on the board of directors of the Christian Academy School System and Leadership Louisville.Key Insights:Steve Hester discusses his work and experience as a physician-leader.Parallel Priorities. In his role as Chief Medical Officer, Dr. Hester believes quality care arises when leaders do the right thing for both patients and employees.Optimizing Workflow. It’s crucial to maximize the time physicians spend with patients: this is the goal of division of labor in a health system. New Work. The pandemic reset the way people think of employment, and many are re-considering what a successful work life looks like. Relevant Links:Read more about Norton HealthcareRead more about Dr. Hester

On this Wednesday's #TheShot of #DigitalHealth Therapy, Jim Joyce and I went down the memory lane of the pharmaceutical industry with the awesome Naomi Fried, Ph.D., CEO of PharmStars - we could have gone for hours but given most of us these days have short attention spans we boiled it down to: 💊 The pharma acronym game 💊 Pharma Startup gap 💊 The oreo cookie effect 💊 "Opening portals of innovation" 💊 oh and..... the art of the deal.... Fun mentions: We got so deep into discussion that we really didn't mention anyone 😂 or if we did, I didn't write it down

Meet Our Guest: Ashley Thompson serves as the Senior Vice President for Public Policy Analysis and Development at the American Hospital Association (AHA). Since 2015, she has been instrumental in providing direction and oversight for the formation and promotion of the AHA's policy positions. Ashley leads the formal policy development process of the AHA, which includes gathering input from prominent hospital leaders to address issues related to advocacy, public policy, and field leadership. Her tenure with the AHA spans over two decades, during which she has held various roles in shaping policy.Key Insights: Ashley Thompson discusses the current state of the healthcare landscape and the challenges faced by hospitals and the workforce.● Post-Pandemic. Ashley suggests that the pivot out of the pandemic should be used as an opportunity to change the way healthcare is delivered and financed in order to increase access, quality, patient satisfaction, and decrease the overall cost of care.● Lemons into Lemonade. After facing some discrimination as a woman in the workplace and being seen as an assistant despite her qualifications, Ashley sees these experiences as opportunities to carve her own path and make a difference.● Being True. Mentors and influencers that have made a difference in her career gave Ashley opportunities and taught her valuable lessons about being authentic and genuine, as well as the importance of flexibility.This episode is hosted by Nancy Howell Agee. She is a member of the Advisory Council for Her Story and President and Chief Executive Officer of Carilion Clinic.Relevant Links: Read Ashley’s Q&AVisit the AHA’s website

Guest bioOriginally from Boston, MA, Liz has 25 years of experience from working on health, Defense, high-tech and economic development issues in Congress and as an attorney and lobbyist. Starting as a student activist, she worked on health, Defense, high-tech and economic development issues in Congress, as an attorney and lobbyist. After meeting lots of entrepreneurs and nonprofits who didn’t know how to navigate government, Liz started G2G (Government2Growth) in 2007. Company bioG2G is a bipartisan team of non-dilutive funding experts and government affairs professionals who work for and with government on the federal, state and local levels – successfully representing bioscience, healthcare, and high-tech innovators, entrepreneurs, research institutions, companies and nonprofits in securing $423 million in non-dilutive government funding to date.FemTech Focus Podcast bioThe FemTech Focus Podcast with Dr. Brittany Barreto is a meaningfully provocative conversational series that brings FemTech experts - including doctors, scientists, inventors, and founders - on air to talk about the innovative technology, services, and products (collectively known as FemTech) that are improving women's health and wellness. Though many leaders in FemTech are women, this podcast is not specifically about female founders, nor is it geared toward a specifically female audience. The podcast gives our host, Dr. Brittany Barreto, and guests an engaging, friendly environment to learn about the past, present, and future of women’s health and wellness. Time Stamps[03:09] Liz Powell’s background [05:29] G2G and Women’s Health[06:31] Women’s Health Innovation Coalition by Springboard Enterprises[09:39] The relationship between Women’s Health and Policy [14:06] Current temperature of Women’s Health of Women’s Health within the US Government[16:45] How do we educate policy makers about women’s health?[19:39] What was the impact of the Dobbs decision on the US Midterm Elections? [25:22] How to get involved in crafting a policy proposal [27:20] Collaborating with the Office of Research on Women’s Health [28:34] If I had a magic wand… [29:31] Letter Writing Campaigns[32:43] Reimbursement as a policy that affects women’s health[36:03] How to get involved with policy and G2G Consulting[37:19] What is an area in women’s health and wellness that still needs innovating?[38:28] What does the femtech industry need the most right now to be successful? ResourcesG2G ConsultingWomen’s Health Innovation Coalition Call To Action!Make sure you subscribe to the podcast, and if you like the show please leave us a review!Subscribe to G2G’s mailings Episode ContributorsLiz Powell LinkedInEmail: [email protected] G2G ConsultingLinkedInTwitter: @G2GConsulting Dr Brittany BarretoLinkedInTwitter: @DrBrittBInstagram: @drbrittanybarreto FemTech FocusLinkedInTwitter: @FemTech_FocusInstagram: @femtechfocus

In this episode we kick off the next chapter of the DTx podcast. We heard you loud and clear - this industry is here to stay and therefore we are moving away from Seasons and going Evergreen - so what does that mean for you? It means we will continue bringing you deep conversations and knowledge from trailblazers, policy makers, associations and of course patients and health consumers. Chandana Fitzgerald, CEO of HealthXL has agreed to continue being my partner on this podcast asking the tough questions and dive into a short recap of last year’s DTx news but also what we are seeing as some of the key trends emerging into 2023 and beyond.   In this episode, we cover: How digital therapeutics have evolved and the future of DTx The Access to Prescription Digital Therapeutics Act of 2022  Digital Therapeutic Alliance approaches to evidence generation and upcoming conferences  Scaling DTx Pharmacy Benefits Management systems Navigating Sick care vs Healthcare And much more! Guest Links and Resources: Chandana Fitzgerald on LinkedIn Visit HealthXL Host Links: Eugene Borukhovich: Twitter | LinkedIn Chandana Fitzgerald, MD: Twitter | LinkedIn YourCoach.health: Website | Twitter Shot of Digital Health with Eugene and Jim Joyce: Website | Podcast App HealthXL: Website | Twitter | Join an Event Digital Health Today and the DTx Podcast would not be possible without the support of leading organizations. Thank you to: • Presenting Partner: Amalgam Rx • Sponsors: Akili • Big Health • Click Therapeutics • Lindus Health Follow Digital Health Today: Browse Episodes • Twitter • LinkedIn • Facebook • Instagram Follow Health Podcast Network: Browse Shows • LinkedIn • Twitter • Facebook • Instagram

Value-based care is emerging in the healthcare ecosystem, largely due to its ability to offer benefits for everyone from patients to physicians to payers. With the power of data and analytics, users can track and improve patient outcomes and control healthcare costs while delivering better quality of care. Patient 360 can provide an optimal experience to patients and healthcare providers with first-rate payment integrity.

At the current rate, about 1 in 8 American women will develop breast cancer in her lifetime. Breast cancer is the second most common cancer among women, but early detection could prevent this growing statistic. In this episode, Dr. Anna Daily and Dr. Brigitte Piniewski join to discuss important movements in breast health, breast cancer, and the future of scientific and crowd-based medical research. Anna Daily and Dr. Piniewski explain the new FemTech platform, Auria: a personalized, innovative at-home breast health assessment. Dr. Anna Daily, PhD, is the Chief Scientific Officer at Namida Lab and the inventor of Auria, the first at-home breast health risk assessment technology that uses tears as a diagnostic biofluid. Dr. Brigitte Piniewski is the Interim Chief Medical Officer at Namida Lab, a medical technology expert, and the author of Wealthcare: Demystifying Web3 and the Rise of Personal Data Economies (available February 2023).  Discussed in this episode: The importance of women’s participation in medical research and science to benefit future generations  Facts and risk factors of breast cancer The importance of detecting the early signs of breast cancer The history of breast cancer and its prevalence in the U.S. What crowd-based technology is and how it can help the prevention of breast cancer How Auria is building a breast health and wellness community  How tears, specifically, can be used as a breast health assessment  Patient medical data, Web3, and the future healthcare economy  “The next generation relies on us to participate in [scientific] crowd-based models if we’re ever going to move away from 1 in 8 women having breast cancer. Whatever is possible to be prevented should be prevented. But prevention isn’t going to happen only using the technologies that we’ve been using in the past.” - Dr. Brigitte Piniewski Related to this episode: Learn more about Auria: www.auria.care   Auria for Physicians & Providers: www.auria.care/providers  Get Dr. Piniewski’s book: Wealthcare Learn more: Using Tears as a Source for Early Detection of Breast Cancer  Learn more: Tears as the Next Diagnostic Biofluid Related episodes featuring FemTech Developments If you want to support this women’s health podcast, leave a review for Fempower Health on iTunes or Spotify. Spread the awareness and share this episode with someone you know! Support and connect with our women’s health community: Subscribe to the Fempower Health Podcast for new episodes every Tuesday Visit us online at www.fempower-health.com  Sign up for our weekly newsletter for the latest announcements, news, and research Follow us on Instagram, Facebook, and Twitter Join Fempower Health on Patreon Email us for inquiries & outreach: [email protected]   **The information shared by Fempower Health is not medical advice but for informational purposes to enable you to have more effective conversations with your doctor. Always talk to your doctor before making health-related decisions. Additionally, the views expressed by the Fempower Health podcast guests are their own and their appearance on the program does not imply an endorsement of them or any entity they represent.** **Contains affiliate links and I will be compensated if you make a purchase after clicking on my links**

📺 Watch this episode on YouTube: https://youtu.be/JG180rbwuLsThere will always be new tech to implement; so, how do we get the adoption bit right?David Kim runs the implementation and adoption teams at 3M’s Health Information Systems division. Karen Snee works in clinical informatics at the Sunshine Coast Health Health Service.3M Health Information Systems is committed to creating more time to care and leading the shift from volume to value-based care. In this episode, Pete features a panel discussion with Karen and David surrounding enabling faster engagement of technology with adoption teams. This episode is chock full of information regarding the successful adoption of technology, including some approaches that are ideal to ensure all stakeholders are satisfied and clinicians aren’t left in the cold. Tune in to learn more!Check out the episode and full show notes here.Loving the show? Leave us a review, and share it with someone who might get some value from it.Keen to take your healthtech to the next level? Become a THT+ Member for access to our online community forum, quarterly summits and more exclusive content. For more information visit here.

Recorded at AWS & Wellington Partners “Health.Tech.Bio - Trends from Across the Pond” symposium at JPM, we welcome industry experts from the Israel Innovation Authority, Exscientia, Sofinnova Partners and Wellington Partners to share their insights on Europe’s unique contributions to healthcare & life sciences innovation. Learn more about how AWS enables healthcare & life sciences startups to grow and thrive at https://aws.amazon.com/startups/ and https://aws.amazon.com/health/.

Episode Sponsor:This episode’s Community Champion Sponsor is Catalyst. To virtually tour Catalyst and claim your space on campus, or host an upcoming event: CLICK HERE---Episode Overview: During this episode, I am honored and excited to welcome Dr. Tom Young, a board-certified family physician, a national mental health expert, and the Founder and Chief Medical Officer of Proem Behavioral Health. While together, Dr. Young shares how his company uses a fresh and innovative approach to deliver mental healthcare through an evidence-based behavioral health workflow engine that simplifies the complex process of delivering mental healthcare and helps providers and researchers get the data they need to make more informed clinical decisions and produce better outcomes for patients suffering from mental illness. Join us as we discuss how Dr. Young and the Proem Behavioral Health team are starting patients on the right path to improved mental health. Let’s go! Episode Highlights:How Dr. Young started his career in the mental healthcare fieldThe ah-ha moments for creating Proem Behavioral HealthWhat biometric markers in behavioral health mean in 2023 and beyondThe effect of the pandemic on mental health and how Proem has helped others during these difficult timesAbout our Guest: Thomas R. Young, MD is a board-certified family physician with more than 35 years of medical experience. He is also a recognized thought leader on ways to better identify and manage mental health disorders, especially among adolescents and teens.Dr. Young currently serves as the Medical Director for Port of Hope in Nampa, ID, where he provides psychiatric services for clients with substance use disorders and co-occurring mental healthdisorders. Dr. Young is also the Founder and Chief Medical Officer of Proem Behavioral Health, a behavioral health technology company providing tools for physicians and researchers to help diagnose psychiatric disorders accurately and efficiently.Previously Dr. Young served for six years as the Medical Director of Idaho Medicaid and has remained active in the formation of medical and mental health policy for the state of Idaho. Dr. Young was also Chief Clinical / Medical Officer of Idaho Medicare QIO Qualis Health.Dr. Young also served as President of Behavioral Imaging Solutions, a technology firm recognized for its application of video imaging for the treatment of children with autism. Most recently, he served as Chief Operating Officer at US Preventive Medicine, a health technology leader in Population Health Management.He is also a successful entrepreneur. His business ventures include Diversified Franchises, LLC which owns a chain of specialty restaurants, a home health business, and Elite Sports Society, a successful sports marketing business where he serves as the business development officer.Links Supporting This Episode:Proem Behavioral Health website: CLICK HEREDr. Thomas Young LinkedIn page: CLICK HEREMike Biselli LinkedIn page: CLICK HEREMike Biselli Twitter page: CLICK HEREVisit our website:

Episode 43: Interview with Professor Stephen Davis & Geoffrey Donnan of the Australian Stroke Alliance. The Australian Stroke Alliance is comprised of more than 30 organisations working together to transform stroke care across Australia and improve the lives of those affected by stroke. They are developing novel mobile imaging, digital health and emergency transport technologies to radically transform stroke outcomes and deliver commercial benefits for all Australians. Rather than transporting patients to hospital, they drive or fly Australian-designed life-saving brain scanning equipment to a patient during the Golden Hour for Stroke, transforming their chances of survival and recovery. For Australians living in rural, remote and Indigenous communities, access to stroke treatment during the Golden Hour for Stroke is limited or non-existent – creating inequity and a major gap in health outcomes. The Australian Stroke Alliance is about equity, world-first innovation and bringing time-critical stroke treatment direct to the patient. About our guests: PROFESSOR GEOFFREY DONNAN AO Geoffrey is a professor of Neurology at The University of Melbourne and former Director of The Florey Institute of Neuroscience and Mental Health. He is the co-lead of the Australian Stroke Alliance and the Frontiers MRFF grant. His research interest is clinical stroke management. He was co-founder, with Professor Stephen Davis, of the Australian Stroke Trials Network. He is the co-chair of the EXTEND group of trials, including the recently published EXTEND IA trial of thrombectomy in acute ischaemic stroke. He was Editor-in-Chief of the International Journal of Stroke and is Past President of the World Stroke Organization. PROFESSOR STEPHEN DAVIS AO Stephen is a professor of Translational Neuroscience at the University of Melbourne, Director of the Melbourne Brain Centre at the Royal Melbourne Hospital and a Past-President of the World Stroke Organization. He co-chairs the Melbourne Mobile Stroke Unit program. His research is focussed on acute therapy for both ischemic stroke and intracerebral haemorrhage, particularly the use of advanced imaging in selection of therapy. He is the co-lead of the Australian Stroke Alliance and the Frontiers MRFF grant. https://austrokealliance.org.au Show Credits: Music intro credit to Jake Dansereau, connect at JAKEEZo on Soundcloud @user-257386777. Our intro welcome is the voice of Caroline Goggin, a stroke survivor and our first podcast guest! Please listen to her inspiring story on Episode 2 of the podcast. Thank you Caroline! Until next time, be sure to give the show a like and share, +follow and connect with us on social or contact us to support us as a show sponsor or become a guest on the Know Stroke Podcast. Visit our new website to apply here: https://www.knowstrokepod.com/ Connect with Us and Share our Show on Social: Website | Linkedin | Twitter | YouTube

Optum Rx positioned the tool as an enhancement of the company's ability to offer a lower price on generics at about a 90% rate.

Steve Irvine, founder and CEO of integrate.ai, explains how a lack of quality data is hindering clinical AI models – and describes how federated learning approaches can enable secure access to a wider array of datasets.

The words healthcare data carry many associations: from frustrations around data interoperability, outrage about the value and monetization of healthcare data, anger due to poor access to medical records by patients, and we could go on.  In the next few episodes, you will hear a little bit more about healthcare data management in the US healthcare system. We’re starting with a discussion recorded at HLTH 2022, where Arif Nathoo - CEO of Komodo Health describes how the company plans to capture and de-identify every encounter patients have with the US healthcare system. Komodo Health is currently tracking individual encounters with the healthcare system for over 330 million patients. Companies such as Pfizer, AppliedVR, Turquoise Health, Janssen, and others, use Komnodo's de-identified patient-level data and insights to inform drug development, discovery, clinical trials, clinical research, and innovation.    Make sure to subscribe to the podcast to be notified about new episodes automatically! In the next episode, you will hear why Palantir Foundy is betting on open data standards in healthcare, what a few healthcare data management vendors think about the current state of interoperability and data governance, and more.  www.facesofdigitalhealth.com Newsletter: fodh.substack.com Leave a rating or a review: lovethepodcast.com/facesofdigitalhealth

📺 Watch this episode on YouTube: https://youtu.be/RQVpuW6L43ACan Australia go from laggard to leap frog when it comes to digital health adoption?Berne Gibbons is the Head of Strategies and Partnerships at InfoMedix. Chris Mitchell is the Chief Information and Digital Officer at Hunter New England LHD. David Tralaggan is a Co-founder of CDIA.In this episode, explore the use of paper in the healthcare sector, how it inhibits digital progress, data accessibility and much more. This one was recorded at the recent Talking HealthTech Spring Summit - a full day virtual event held every quarter for THT+ Members. For more information and learn about the upcoming Summer Summit in 2023, visit the Talking HealthTech website.Check out the episode and full show notes here.Loving the show? Leave us a review, and share it with someone who might get some value from it.Keen to take your healthtech to the next level? Become a THT+ Member for access to our online community forum, quarterly summits and more exclusive content. For more information visit here.

ONCE UPON A GENE - EPISODE 171 Never Give Up - Two Decades of Struggles From Diagnosing Their Children to Starting a Clinical Trial For Aspartylglucosaminuria with Rare Mom Julia Taravella Julia Taravella is a mom to two adult children, Alexander and Daniel, and she's the founder of the Rare Trait Hope Fund. Julia's sons didn't have a diagnosis for 16 years until she went above and beyond to seek out answers and use the genetic data available to her to reveal a diagnosis of Aspartylglucosaminuria (AGU), a rare, fatal, lysosomal storage disorder.  EPISODE HIGHLIGHTS Can you tell us about your sons and their diagnosis journey? Alexander and Daniel are 22 and 27. In kindergarten and first grade, Daniel was doing below average. Daniel was 5 years old when his brother Alexander was born. Alexander started early intervention, but started to have the same delays as Daniel. Having two children presenting the same developmental delays, I suspected it was genetic, but it was difficult to get genetic testing at that time. I sought consultations with physicians and specialists, the boys underwent testing, and all results revealed they were within the expected range. A direct-to-consumer genetic test came out on the market and I bought two of them for my husband and I, figuring there may be something uncovered through our DNA. We went on to test both kids and close relatives too and the results were inconclusive. I dug deeper by downloading all of the data from the testing website and went back to doctors with it, but I wasn't taken seriously. I found a person in bioinformatics who agreed to analyze and clean up the data. When the data was returned, I took genetics classes for 6 months, wrote a program to analyze the data and determined my sons had AGU. The diagnosis was confirmed by doctors through further blood and urine testing. What did you do after getting a diagnosis?  I attended a conference and connected with new families with other glycoprotein lysosomal diseases and it helped to meet them. I had hope that something could be done and I frantically started writing emails to anyone I could find in the published AGU literature. I wrote about 200 emails and through those emails I connected with a Finnish doctor who invited me to go to Finland to meet with her. We stopped in Germany on the way and connected with a biochemist to discuss potential treatment options.  What should everyone watch out for when developing gene therapy programs? It's important to have a signed sponsorship agreement about how research and funding is handled without knowing what you'll get in return. Take small steps and don't invest everything you've raised at once to test if you'll receive the results you want within the time frame you've set. Step-by-step developments will help develop a rapport with your researcher to develop trust and gain understanding about where funding goes. Also be sure to understand who is working on what and maintain open lines of communication with everyone. LINKS & RESOURCES MENTIONED Rare Trait Hope Fund https://www.raretrait.com/ 23andMe https://www.23andme.com/ ONCE UPON A GENE - EPISODE 154 - A Groundbreaking Gene Therapy In Record Time to Cure His Son with SPG50 Sets a New Course For Future Rare Disease Treatments with Terry Pirovalakis https://effieparks.com/podcast/episode-154-terry-pirovolakis-groundbreaking-gene-therapy CONNECT WITH EFFIE PARKS Website https://effieparks.com/ Twitter https://twitter.com/OnceUponAGene Instagram https://www.instagram.com/onceuponagene.podcast/?hl=en Built Ford Tough Facebook Group https://www.facebook.com/groups/1877643259173346/ Interested in advertising on Once Upon a Gene? Email [email protected] for more information!

Meet Peter McCanna:Peter McCanna is chief executive officer (CEO) at Baylor Scott & White Health, the largest not- for-profit health system in Texas. Through 51 hospitals and more than 1,200 access points, including flagship academic medical centers in Dallas, Fort Worth and Temple, the system offers the full continuum of care, from primary to award-winning specialty care, as well as an array of virtual and in-home services. Previously, McCanna served as Baylor Scott & White’s president. Now, in his role as CEO, McCanna is leading the health system’s transformation to deliver experiences that go beyond customers’ traditional expectations of healthcare.  Key Insights:Peter McCanna believes it is not enough to preserve legacy systems; healthcare must evolve: Customer Centered. The intersection of consumerism and new technological tools demand a new destination for healthcare where the customer must be at the center.Addressing Injustice. McCanna points out that there are big gaps in care for different populations—he describes these gaps as a public health problem. Diverse Thinking. According to McCanna, the executive of the future must be comfortable with diverse thinking, and must have a diverse skill set to implement change. This episode was made possible by our partnership with Citi.Relevant Links:Get to know Pete McCannaRead more about Baylor Scott & White Health

CRM strategies are increasingly being adopted in the healthcare industry. By leveraging data-driven CRM strategies, healthcare organizations have an efficient way to better understand and engage with their patients. Gaining powerful insights into your patients’ behaviors, preferences, and needs results in a better understanding of your patient population and the ability to create more effective marketing campaigns. Listen to Chris Dufresne, VP of Digital Products and Marketing Technology at Allina Health, and Alan Tam, VP of Marketing at Actium Health, as they discuss adoption, misconceptions, pitfalls, and effectiveness of CRM technologies. Hosted on Acast. See acast.com/privacy for more information.

On this Wednesday's #TheShot of #DigitalHealth therapy, Jim Joyce and I had the pleasure of spending time with the one and only Ann Mond Johnson, CEO of the American Telemedicine Association.. So many topics, so little time: 🖥 US Healthcare patterns 🖥 Data Fantasy 😂 - (my new favorite term) 🖥 The myths of Telehealth 🖥 Telehealth policy 🖥 oh... and ATA conference Mar 4-6 (https://gotelehealth.org/ata-2023/) Fun mentions as always : Lee Shapiro Jane Sarasohn-Kahn Joseph Kvedar Kyle Zebley Sreekanth Chaguturu Robert Wachter Bart Demaerschalk MD

Meet Our Guest: Meet Shellye Archambeau, an accomplished CEO and Board Director who has a history of success in building brands, leading high-performance teams and growing organizations. With her experience as the former CEO of MetricStream, Archambeau currently holds board positions at major companies such as Verizon, Roper Technologies and Okta. Additionally, she serves as a strategic advisor for Forbes Ignite and holds the position of President of Arizona State University. Archambeau also lends her expertise to non-profit organizations Catalyst and Braven as a board member. Her book, "Unapologetically Ambitious: Take Risks, Break Barriers and Create Success on Your Own Terms" offers inspiration and practical tools to help readers navigate the challenges and trade-offs of creating the life they want.Key Insights: Shellye Archambeau discusses her book "Unapologetically Ambitious: Take Risks, Break Barriers and Create Success on Your Own Terms" and offers valuable advice to other aspiring leaders on recognizing opportunities, finding mentors, and creating effective networks.● From 16 to CEO. Shelley had a desire to become CEO at the age of 16 after her involvement in various clubs and organizations developed a desire for leadership.● Strength and Resilience. After being a minority in business her entire life, Shellye was able to use this to her advantage when it came to operational skills in unique roles. It was what set her apart from others and gave her insight to a different mindset in business.● Be Comfortable With the Uncomfortable. Taking risks isn’t always comfortable. Shellye advises women to be sure to take calculated risks because if you don’t, you’ll miss out on opportunities and rewards.This episode is hosted by Gary Bisbee, Ph.D., MBA​, Founder, Chairman & CEO Think Medium.Relevant Links: Check out Shellye’s websiteFollow Shellye on TwitterOrder a copy of Shellye’s book

Intro music by Scott Holmes

With the federal debt limit reached, Treasury Secretary Janet Yellen has begun using “extraordinary measures” to pay the government’s bills. The pressure will continue until Congress raises the debt limit.  But what does it all mean for healthcare? John and David share their thoughts.ABOUT CARETALKCareTalk is a weekly podcast that provides an incisive, no B.S. view of the US healthcare industry. Join co-hosts John Driscoll (President U.S. Healthcare and EVP, Walgreens Boots Alliance) and David Williams (President, Health Business Group) as they debate the latest in US healthcare news, business and policy.GET IN TOUCHBecome a CareTalk sponsorGuest appearance requestsVisit us on the webFOLLOW CARETALKSpotifyApple PodcastsGoogle PodcastsFollow us on LinkedIn